Drug Development

Listings

• 

  Ku70 peptide

  Drug Development Shirley (New York) February 22, 2019 10.00 Dollar US$

  The p70/p80 autoantigen is a nuclear complex consisting of two subunits with molecular masses of approximately 70 and 80 kDa. The complex functions as a single-stranded DNA-dependent ATP-dependent helicase. The complex may be involved in the repair o...

• 

  WIF1 peptide

  Drug Development Shirley (New York) February 22, 2019 10.00 Dollar US$

  The protein encoded by this gene functions to inhibit WNT proteins, which are extracellular signaling molecules that play a role in embryonic development. This protein contains a WNT inhibitory factor (WIF) domain and five epidermal growth factor (EG...

• 

  Antibody-Drug Conjugate

  Drug Development Shirley (New York) February 11, 2019 Check with publisher

  Antibody-drug conjugates (ADCs) are an important class of highly potent biopharmaceutical drugs, which are created by coupling a small molecule anticancer drug or a therapeutic agent to an antibody that specifically targets a certain tumor marker. Th...

• 

  MED4 Peptide

  Drug Development Shirley (New York) January 22, 2019 Check with publisher

  This gene encodes a component of the Mediator complex. The Mediator complex interacts with DNA-binding gene-specific transcription factors to modulate transcription by RNA polymerase II. Alternatively spliced transcript variants encoding multiple iso...

• 

  LZTR1 Peptide

  Drug Development Shirley (New York) January 22, 2019 Check with publisher

  This gene encodes a member of the BTB-kelch superfamily. Initially described as a putative transcriptional regulator based on weak homology to members of the basic leucine zipper-like family, the encoded protein subsequently has been shown to localiz...

• 

  Peptide Drug Bioconjugations

  Drug Development Shirley (New York) January 11, 2019 Check with publisher

  Bioconjugation is a chemical strategy to form a stable covalent link between two molecules, at least one of which is a biomolecule. The field of bioconjugation has had a considerable impact on academic research, clinical diagnostics and the productio...

• 

  Metabolites Synthesis

  Drug Development Shirley (New York) January 10, 2019 Check with publisher

  Metabolites of pharmaceutical compounds are pivotal to comprehending drug metabolism, potential drug interactions, and human drug metabolizing enzymes. Primary metabolites are synthesized by the cell because they are critical for biological growth li...

• 

  Reference Compounds Synthesis

  Drug Development Shirley (New York) January 10, 2019 Check with publisher

  ISO classifies materials into two groups as reference materials (RMs) and certified reference materials (CRMs). Reference materials (reference compounds), established for measuring the quality of analysis, are critical for any measurement process cha...

• 

  Impurities Synthesis

  Drug Development Shirley (New York) January 10, 2019 Check with publisher

  Impurity profile studies play significant roles in active pharmaceutical ingredient (API) development, which are closely related to the quality, safety and efficacy of drug products. And the impurity profile of API for drug products requires studying...

• 

  Intermediates Synthesis

  Drug Development Shirley (New York) January 10, 2019 Check with publisher

  Owing to chirality is a pivotal factor in the safety and efficacy of many drug products, the production of single enantiomers of drug intermediates has become increasingly important in the pharmaceuticals industry. It has been seen that the increasin...

• 

  Building Block Synthesis

  Drug Development Shirley (New York) January 10, 2019 Check with publisher

  During the last decades, the synthesis of building blocks has been explored by numerous groups, which are used in pharmaceutical products and other biologically active substances. Building blocks are important intermediates for many drugs and have ma...

• 

  API Synthesis

  Drug Development Shirley (New York) January 10, 2019 Check with publisher

  Active Pharmaceutical Ingredient (API) is defined by U.S. Food & Drug Administration as: any substance or mixture of substances intended to be used as the active ingredient in the manufacture of a drug (medicinal) product. Such substances are int...